newsfilter
← Latest News
GlobeNewswire·

Morphic to Participate in RBC Capital Markets Global Healthcare Conference

WALTHAM, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ:MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today